Common Diabetes Drug May Help Prevent HIV From Returning
Scientists at Gladstone Institutes have discovered that a common diabetes drug may help stop HIV from returning after treatment. The drug, Metformin, could play a role in keeping the virus inactive inside the body.This research offers new hope for people living with HIV, who currently need lifelong medication to control the infection.
Even with treatment, HIV is not fully removed from the body. Instead, it hides in certain immune cells known as “reservoirs.”If medication is stopped, the virus often becomes active again. As a result, it can quickly spread and damage the immune system.
Rare cases offer important clues
Scientists have long studied rare individuals who can control HIV even after stopping treatment. In these cases, the virus remains dormant for extended periods.Researchers found that specific genes and immune cells help maintain this inactive state. These act like “locks” that prevent the virus from reactivating.
Role of metformin in keeping HIV dormant
The study shows that metformin may help activate one of these protective mechanisms. As a result, it can reduce the chances of the virus becoming active again.In lab tests, cells treated with metformin showed a reduced ability for HIV to reactivate. Therefore, the drug could potentially delay or prevent viral rebound.
A step toward long term control
Metformin is already widely used, affordable, and considered safe. This makes it a promising candidate for future HIV treatment strategies.However, the research is still in early stages. Clinical trials will be needed to confirm whether the drug works effectively in patients.
If successful, this approach could reduce the need for daily HIV medication. It may help patients maintain long-term control of the virus.Overall, the findings represent an important step toward new treatment options. They show how existing drugs can be repurposed to tackle complex diseases like HIV.
